Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06092970 · ClinicalTrials.gov registry record
An Evaluation of Patient Reported Outcomes and Clinical Outcomes
A clinical trial of Post-Operative Complications in Cardiac Surgery, sponsored by Renibus Therapeutics.
- Active
- Registry status
- 379
- Enrollment target
- 20
- Study locations
NCT06092970: Active study of Post-Operative Complications in Cardiac Surgery, sponsored by Renibus Therapeutics.
NCT06092970 is a study of Post-Operative Complications in Cardiac Surgery that is active but no longer recruiting, run by Renibus Therapeutics. The registered enrollment target is 379 participants. The trial reports 20 study locations across 12 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06092970, a study of Post-Operative Complications in Cardiac Surgery, is active but no longer recruiting, sponsored by Renibus Therapeutics.
- ACTIVE NOT RECRUITING
- Registry status
- 379 participants
- Enrollment target
- 20
- Study locations
Study Summary
This extension study is being conducted to assess the following objectives through 12 months post-cardiac surgery: * Patient reported outcomes (PRO), using the EQ-5D questionnaire * Clinical outcomes
Primary Outcome
To evaluate patient reported outcomes (PRO) using the EQ-5D questionnaire
Conditions Studied
Interventions
- DRUG Placebo
- DRUG RBT-1
Study Locations (20)
Michigan
- Research Site - Ann Arbor
- Research Site - Lansing
- Research Site - Midland
- Research Site - Royal Oak
Indiana
- Research Site - Fort Wayne
- Research Site - Indianapolis
- Research Site - Indianapolis
California
- Research Site - San Francisco
- Research Site - Stanford
Florida
- Research Site - Atlantis
- Research Site - Gainesville
Georgia
- Research Site - Athens
- Research Site - Atlanta
Alabama
- Research Site - Huntsville
District of Columbia
- Research Site - Washington D.C.
Kansas
- Research Site - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 379 participants |
| Start Date | 2023-10-16 |
| Est. Completion | 2026-06-30 |
What the registry record for NCT06092970 still lists
NCT06092970 is an observational study that tracks outcomes without assigning an intervention. The registered 379 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Post-Operative Complications in Cardiac Surgery appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT06092970 names 20 study sites across 12 states, led by Michigan, Indiana, California.
Frequently Asked Questions
What is clinical trial NCT06092970 about?
NCT06092970 is a clinical study titled "An Evaluation of Patient Reported Outcomes and Clinical Outcomes". This extension study is being conducted to assess the following objectives through 12 months post-cardiac surgery: * Patient reported outcomes (PRO), using the EQ-5D questionnaire * Clinical outcomes
What is the current status of trial NCT06092970?
This trial is currently active not recruiting. The enrollment target is 379 participants. The study started on 2023-10-16. Estimated completion is 2026-06-30.
What conditions does trial NCT06092970 study?
This clinical trial studies the following conditions: Post-Operative Complications in Cardiac Surgery.
What interventions are being tested in trial NCT06092970?
The interventions under investigation include: Placebo (DRUG), RBT-1 (DRUG).
Who is sponsoring clinical trial NCT06092970?
This trial is sponsored by Renibus Therapeutics, which has 9 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06092970 being conducted?
This trial has 20 study locations across Alabama, California, District of Columbia, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04560673 · 380 participants · Phase 2
Duloxetine and Neurofeedback Training for the Treatment of Chemotherapy Induced Peripheral Neuropathy
- NCT04777357 · 380 participants · Phase 3
A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.
- NCT04821154 · 380 participants
Persona Revision Knee System Outcomes
- NCT05102019 · 380 participants · NA
Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI